Clin2
NCT07269691Possibly a fitNot yet recruiting

Radioactive seed marking before chemo for breast cancer

Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer

Part of Cancer, Skin clinical trials.

This trial is testing whether placing a tiny radioactive seed in your breast tumor before chemotherapy can help doctors see the best response and improve long-term outcomes. Participants get standard chemo plus the seed, and the study checks how often the tumor completely disappears.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
194 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 70 years old.
  • You have been diagnosed with early or advanced breast cancer that has not spread to distant organs.
  • You have not had any prior treatment for this cancer (like chemo, radiation, or targeted therapy).
  • Your cancer is in one breast only and has not been treated before.
  • Your overall health is good enough for standard chemotherapy (ECOG score 0 or 1).
  • You are not pregnant, breastfeeding, or planning to become pregnant, and you will use effective birth control if needed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06903468Recruiting
New cavity marking technique for breast cancer surgery and radiation

This trial tests a new way to mark the area where breast cancer is removed during lumpectomy with oncoplastic reconstruction. The goal is to make follow-up radiation more precise and reduce the need for additional surgeries.

Gainesville, Florida
NCT07188246Recruiting· Phase 2
Radiation and immunotherapy before chemo for breast cancer

This trial tests a new approach for breast cancer that combines a short course of focused radiation (SBRT) with an injection of the immunotherapy drug pembrolizumab directly into the tumor, followed by standard chemotherapy before surgery. The goal is to see if this combination helps shrink the tumor more effectively before surgery.

London, Ontario
NCT07277777Not yet recruiting· Phase 2
Radioactive seeds plus immunotherapy for solid tumors

This trial tests whether placing tiny radioactive seeds directly into a tumor, combined with immunotherapy (a drug that helps your immune system attack cancer), can help treat cancers that are new, have come back, or have spread. It's for people who can safely have the seed procedure and are eligible for immunotherapy.

Jinan, Shandong
NCT07333664Not yet recruiting· Phase 2
Radioactive seed implants plus standard therapy for multiple metastatic tumors

This trial tests a treatment that places tiny radioactive seeds directly into some of your tumors, combined with your usual cancer therapy. It is for people who have 6 to 10 tumors that have spread to other parts of the body (not the brain). The goal is to see if adding this implant procedure helps control the tumors better.

Jinan, Shandong
NCT07437625Not yet recruiting· Phase 2
Seed implants plus freezing for advanced cancer with many or large tumors

This trial tests a combination of two local treatments—radioactive seed implants and cryoablation (freezing)—for people with cancer that has spread to multiple sites or created large tumors that can't be surgically removed. The goal is to see if targeting up to five specific spots can control the disease and reduce symptoms.

Jinan, Shandong
NCT07333651Not yet recruiting· Phase 2
Radioactive seeds plus systemic therapy for oligoprogressive cancers

This trial tests a procedure that places tiny radioactive seeds directly into tumors that have started growing again in patients with lung or colorectal cancer that has spread. It combines this with standard drug therapy to see if it can better control the disease.

Jinan, Shandong

Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.